They act on the same receptor pathway your natural GLP-1 uses, but they are designed to last much longer in the body
Juliette Cubanski, vice president and director of Medicare policy at KFF, put it plainly to CBS News: "In the short term, we have this temporary program, and then no clear path forward yet as to what will happen at the end of 2027." CMS Administrator Mehmet Oz framed the Bridge as a stopgap at launch, according to AJMC, but has not indicated when or whether a permanent mechanism will follow
Those exploring GLP-1 use during breastfeeding should consult their physician for any supplement decisions
Normally, we hear side effect and say, Uh-oh! But this was an unexpectedly positive side effect serious weight loss
In vitro assays show relatively balanced GLP-1 and glucagon receptor activity, with stronger GIP receptor potency reported in some assay systems